NHS England Cancer Diagnostics event

Posted by 2162 on July 19, 2018

NHS England Cancer Diagnostics event

July 19, 2018 at 10:01 PM

Samantha Lear, board director for membership, attended NHS England’s “Cancer Diagnostic event: How can scientists contribute towards meeting rising demand?” on 18th July. The aim of the event was to bring Healthcare Scientists together to discuss how to improve the cancer diagnostic pathway to cope with increasing pressure on services.

Following the Five Year Forward next steps agenda, Healthcare scientists are encouraged to have a bigger voice at strategic and national level, and this event was attended by Healthcare Scientists from various specialisms. Although Audiology may not be considered to be a direct part of the cancer diagnostic pathway, audiologists do see patients who are referred onto the pathway, and cancer treatments (e.g. chemotherapy, radiotherapy and antibiotic regimes) are known to be ototoxic. Thus, the importance of monitoring for hearing loss, tinnitus and vestibular disturbances needs to be recognised.

BAA are always keen to ensure that healthcare scientists in Audiology are informed and contribute to developments at a strategic level. This event offered the chance to consider how Audiology fits into the “bigger picture” of health care pathways, and encouraged joint working with other professionals. Those in attendance sent a strong message to NHS England that Healthcare Scientists have much untapped knowledge and expertise, and if given the space to innovate, can improve services significantly.